Published in J Exp Med on March 01, 1989
Surface expression of a T cell receptor beta (TCR-beta) chain in the absence of TCR-alpha, -delta, and -gamma proteins. J Exp Med (1991) 1.39
A novel family of human leukocyte antigen class II receptors may have its origin in archaic human species. J Biol Chem (2013) 1.29
Presentation of antigen by mixed isotype class II molecules in normal H-2d mice. J Exp Med (1992) 1.02
Structural requirements for pairing of alpha and beta chains in HLA-DR and HLA-DP molecules. J Exp Med (1990) 0.95
In vivo expression and function of hybrid Ia dimers (E alpha A beta) in recombinant and transgenic mice. J Exp Med (1989) 0.87
Existence of mixed isotype A beta E alpha class II molecules in Ed alpha gene-introduced C57BL/6 transgenic mice. Immunology (1990) 0.80
Antigen-reactive T cell clones restricted by mixed isotype A beta d/E alpha d class II molecules. J Exp Med (1990) 0.79
Structure of the human class I histocompatibility antigen, HLA-A2. Nature (1987) 14.54
Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system. Nature (1974) 13.24
Antigen-inducible, H-2-restricted, interleukin-2-producing T cell hybridomas. Lack of independent antigen and H-2 recognition. J Exp Med (1981) 12.03
Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and Ia antigens. J Immunol (1980) 8.56
Establishment and characterization of BALB/c lymphoma lines with B cell properties. J Immunol (1979) 6.70
One-way stimulation in mixed leukocyte cultures. Science (1966) 6.62
Deglycosylation of glycoproteins by trifluoromethanesulfonic acid. Anal Biochem (1981) 6.45
The major histocompatibility complex determines susceptibility to cytotoxic T cells directed against minor histocompatibility antigens. J Exp Med (1975) 5.83
The relation between major histocompatibility complex (MHC) restriction and the capacity of Ia to bind immunogenic peptides. Science (1987) 5.32
The class II molecules of the human and murine major histocompatibility complex. Cell (1984) 4.34
Monoclonal antibody against an Ir gene product? J Exp Med (1980) 3.88
Antigen recognition by H-2-restricted T cells. II. A tryptic ovalbumin peptide that substitutes for processed antigen. J Immunol (1984) 3.72
Interaction between a "processed" ovalbumin peptide and Ia molecules. Proc Natl Acad Sci U S A (1986) 2.42
Antigen-specific. I region-restricted interactions in vitro between tumor cell lines and T cell hybridomas. J Immunol (1982) 2.26
Variable synthesis and expression of E alpha and Ae (E beta) Ia polypeptide chains in mice of different H-2 haplotypes. Immunogenetics (1981) 2.13
Antigen presentation by splenic B cells: resting B cells are ineffective, whereas activated B cells are effective accessory cells for T cell responses. J Immunol (1985) 1.91
Reticulum cell neoplasm, type B, or the "Hodgkin's-like lesion" of the mouse. J Natl Cancer Inst (1968) 1.89
Allele-specific control of Ia molecule surface expression and conformation: implications for a general model of Ia structure-function relationships. Proc Natl Acad Sci U S A (1987) 1.67
DNA sequence of the gene encoding the E alpha Ia polypeptide of the BALB/c mouse. Science (1982) 1.46
Peptide sequences of T-cell receptor delta and gamma chains are identical to predicted X and gamma proteins. Nature (1988) 1.41
Predominant role of amino-terminal sequences in dictating efficiency of class II major histocompatibility complex alpha beta dimer expression. Proc Natl Acad Sci U S A (1987) 1.38
Small subunit of I-A subregion antigens determines the allospecificity recognized by a monoclonal antibody. Nature (1980) 1.38
Cross-blocking studies with monoclonal antibodies against I-A molecules of haplotypes b, d and k. Eur J Immunol (1982) 1.35
Antigen-specific, H-2-restricted helper T cell hybridomas. J Exp Med (1982) 1.29
A novel HLA class II molecule (DR alpha-DQ beta) created by mismatched isotype pairing. Nature (1987) 1.26
Structural mutation affecting intracellular transport and cell surface expression of murine class II molecules. J Exp Med (1988) 1.26
Interaction between I region loci influences the expression of a cell surface Ia antigen. Proc Natl Acad Sci U S A (1980) 1.20
Studies Utilizing murine T cell clones: Ir genes, Ia antigens and MLR stimulating determinants. Immunol Rev (1981) 1.19
Cotransfer of the Ed alpha and Ad beta genes into L cells results in the surface expression of a functional mixed-isotype Ia molecule. Proc Natl Acad Sci U S A (1986) 1.17
Identification of an immunodominant region on the I-A beta chain using site-directed mutagenesis and DNA-mediated gene transfer. J Exp Med (1988) 1.03
Ia-specific mixed leukocyte reactive T cell hybridomas: analysis of their specificity by using purified class II MHC molecules in synthetic membrane system. J Immunol (1986) 1.01
Characterization of the molecules on SJL/J lymphomas which stimulate syngeneic T cells. J Immunol (1985) 0.91
Properties of reticulum-cell sarcomas in SJL/J mice. I. Proliferative response to tumor cells of T-derived lymphoid cells from normal mice. Int J Cancer (1974) 0.85
Evidence for the association of I-A and I-E molecules in d-haplotype mice. Mol Immunol (1986) 0.84
Transfected human B lymphoblastoid cells express the mouse Ad beta-chain in association with DR alpha. J Immunol (1986) 0.81
Stimulation of autologous blood lymphocytes by malignant lymphoma cells and homogenates. Br J Cancer (1976) 0.78
Relationship between leukemia antigens and stimulation in mixed leukocyte culture. J Natl Cancer Inst (1977) 0.78
Imbalanced MHC class II molecule expression at surface of murine B cell lymphomas. J Exp Med (1986) 0.77
The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J Immunol (1994) 4.37
Several common HLA-DR types share largely overlapping peptide binding repertoires. J Immunol (1998) 3.95
Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules. Cell (1993) 3.80
Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. Immunity (1994) 2.90
The small subunit of HL-A antigens is beta 2-microglobulin. J Exp Med (1973) 2.68
Thymus-derived (T) cell immunoglobulins. Presence of a receptor site for IgG and absence of large amounts of "buried" Ig determinants on T cells. J Exp Med (1972) 2.35
Resident pulmonary lymphocytes expressing the gamma/delta T-cell receptor. Nature (1989) 2.16
Role of HLA-A motifs in identification of potential CTL epitopes in human papillomavirus type 16 E6 and E7 proteins. J Immunol (1994) 2.07
In vivo administration of monoclonal antibodies to the CD3 T cell receptor complex induces cell death (apoptosis) in immature thymocytes. J Immunol (1991) 2.00
The thymus has two functionally distinct populations of immature alpha beta + T cells: one population is deleted by ligation of alpha beta TCR. Cell (1989) 1.91
Studies on receptors for IgG on epithelial cells of the rat intestine. J Immunol (1977) 1.82
Peptide binding to the most frequent HLA-A class I alleles measured by quantitative molecular binding assays. Mol Immunol (1994) 1.80
Immunological identity of the small subunit of HL-A antigens and beta2-microglobulin and its turnover on the cell membrane. Proc Natl Acad Sci U S A (1974) 1.80
Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs. Immunol Today (1996) 1.79
Limited receptor repertoire in a mycobacteria-reactive subset of gamma delta T lymphocytes. Nature (1989) 1.77
Expression of a hybrid immunoglobulin-T cell receptor protein in transgenic mice. Cell (1989) 1.66
Invariant chain peptides in most HLA-DR molecules of an antigen-processing mutant. Science (1992) 1.63
IgD: a major immunoglobulin on the surface of lymphocytes from patients with chronic lymphatic leukemia. J Immunol (1974) 1.56
Mitogen activation of human chronic lymphatic leukemia cells. I. Synthesis and secretion of immunoglobulin. J Immunol (1977) 1.52
Definition of an HLA-A3-like supermotif demonstrates the overlapping peptide-binding repertoires of common HLA molecules. Hum Immunol (1996) 1.52
Regulation of catabolism of IgM heavy chains in a B lymphoma cell line. J Biol Chem (1982) 1.44
Peptide sequences of T-cell receptor delta and gamma chains are identical to predicted X and gamma proteins. Nature (1988) 1.41
Surface expression of a T cell receptor beta (TCR-beta) chain in the absence of TCR-alpha, -delta, and -gamma proteins. J Exp Med (1991) 1.39
mu-Chains from a nonsecretor B cell line differ from secreted mu-chains at the C-terminal end. J Immunol (1978) 1.36
Binding of a peptide antigen to multiple HLA alleles allows definition of an A2-like supertype. J Immunol (1995) 1.35
Several HLA alleles share overlapping peptide specificities. J Immunol (1995) 1.33
Physical association of CD4 with the T cell receptor. J Immunol (1992) 1.28
Specificity and degeneracy in peptide binding to HLA-B7-like class I molecules. J Immunol (1996) 1.21
Analysis of the interaction site for the self superantigen Mls-1a on T cell receptor V beta. J Exp Med (1991) 1.13
Alpha beta T cell receptor and CD3 transduce different signals in immature T cells. Implications for selection and tolerance. J Immunol (1989) 1.12
Prominent roles of secondary anchor residues in peptide binding to HLA-A24 human class I molecules. J Immunol (1995) 1.06
Derivation of HLA-A11/Kb transgenic mice: functional CTL repertoire and recognition of human A11-restricted CTL epitopes. J Immunol (1997) 1.06
Potent immunogenic short linear peptide constructs composed of B cell epitopes and Pan DR T helper epitopes (PADRE) for antibody responses in vivo. Vaccine (1997) 1.05
Activation induces a rapid reorganization of spectrin in lymphocytes. Cell (1988) 1.04
Tunicamycin inhibits the expression of membrane IgM in the human lymphoblastoid cell line Daudi. Mol Immunol (1983) 1.03
Ia-specific mixed leukocyte reactive T cell hybridomas: analysis of their specificity by using purified class II MHC molecules in synthetic membrane system. J Immunol (1986) 1.01
Activation of T and B lymphocytes in vitro: presence of beta2-microblobulin determinants on allogeneic effect factor. Proc Natl Acad Sci U S A (1975) 0.99
Effect of anti-beta2-microglobulin on antigen and allogeneic lymphocyte-induced proliferation of human lymphocytes. J Immunol (1975) 0.97
Physical dissociation of the TCR-CD3 complex accompanies receptor ligation. J Exp Med (1995) 0.95
T-cell development and transmembrane signaling: changing biological responses through an unchanging receptor. Immunol Today (1991) 0.94
Expression of functional alpha beta T cell receptor gene rearrangements in suppressor T cell hybridomas correlates with antigen binding, but not with suppressor cell function. J Immunol (1990) 0.93
Cloned suppressor T cells derived from mice tolerized with conjugates of antigen and monomethoxypolyethylene glycol. Relationship between monoclonal T suppressor factor and the T cell receptor. J Immunol (1990) 0.92
Anti-immunoglobulin stimulation of murine lymphocytes. II. Identification of cell surface target molecules and requirements for cross-linkage. J Immunol (1976) 0.92
Relationship between T cell receptors and antigen-binding factors. II. Common antigenic determinants and epitope recognition shared by T cell receptors and antigen-binding factors. J Immunol (1989) 0.91
Translocation of spectrin and protein kinase C to a cytoplasmic aggregate upon lymphocyte activation. Proc Natl Acad Sci U S A (1992) 0.91
Relationships between antigen-specific helper and inducer suppressor T cell hybridomas. J Immunol (1990) 0.90
Studies on the cytophilic properties of human beta2 microglobulin. J Immunol (1975) 0.89
Studies on the question of conventional immunoglobulin on thymocytes from primitive vertebrates. II. Delineation between Ig-specific and cross-reactive membrane components. J Immunol (1978) 0.88
Epitopes associated with major histocompatibility complex (MHC) restriction site of T cells. IV. I-J epitopes on MHC-restricted cloned T cells. Eur J Immunol (1988) 0.88
Inhibition of allograft rejection by anti-T-cell receptor-alpha beta monoclonal antibodies preserving resistance to bacterial infection. Immunology (1994) 0.87
DNP-specific/class I MHC-restricted suppressor molecules bear determinants of the T cell receptor alpha- and beta-chains. The V beta 8+ chain dictates restriction to either K or D. J Immunol (1990) 0.87
Developmental regulation of the TCR zeta-chain. Differential expression and tyrosine phosphorylation of the TCR zeta-chain in resting immature and mature T lymphocytes. J Immunol (1994) 0.86
Amino terminal sequences of heavy and light chains of chicken anti-dinitrophenyl antibody. J Immunol (1971) 0.86
The unblocked N-terminal sequence of chicken IgG lambda-like light chains. J Immunol (1970) 0.86
Two distinct HLA-A*0101-specific submotifs illustrate alternative peptide binding modes. Immunogenetics (1997) 0.86
Lipopeptide particles as the immunologically active component of CTL inducing vaccines. Vaccine (1999) 0.85
Structural analysis of the mu-chains synthesized by fetal liver hybridomas. J Immunol (1981) 0.85
Preparation and characterization of a "pan-reactive" rabbit anti-mouse T-cell receptor antiserum. Mol Immunol (1986) 0.85
Expression of membrane IGM by a human B lymphoblastoid cell line in the presence of monensin. Mol Immunol (1983) 0.84
In vitro induction of primary, antigen-specific CTL from human peripheral blood mononuclear cells stimulated with synthetic peptides. Mol Immunol (1995) 0.84
Biochemical identification of I-J as a novel dimeric surface molecule on mouse helper and suppressor T cell clones. Int Immunol (1989) 0.83
Studies on the question of conventional immunoglobulin on thymocytes from primitive vertebrates. I. Presence of anti-carbohydrate antibodies in rabbit anti-trout Ig sera. J Immunol (1978) 0.82
Studies on the cytophilic properties of human beta2-microglobulin. II. The role of histocompatibility antigens. Scand J Immunol (1979) 0.82
Expression and function of mixed isotype MHC class II molecules in normal mice. J Immunol (1993) 0.82
A T helper cell hybridoma produces an antigen-specific regulatory activity. Relationship to the T cell receptor by serology and antigenic fine specificity. J Immunol (1991) 0.82
Pools of lipidated HTL-CTL constructs prime for multiple HBV and HCV CTL epitope responses. Vaccine (1998) 0.81
Passive cutaneous anaphylaxis in chickens. Proc Soc Exp Biol Med (1968) 0.81
Monoclonal antibodies specific for antigens expressed by rat type II alveolar epithelial and nonciliated bronchiolar cells. Exp Lung Res (1989) 0.80
Relationship between T cell receptors and antigen-binding factors. I. Specificity of functional T cell receptors on mouse T cell hybridomas that produce antigen-binding T cell factors. J Immunol (1989) 0.80
Biochemical and ultrastructural characterization of a novel cell structure associated with immunoglobulin secretion in B-lymphocytes. J Mol Cell Immunol (1987) 0.80
Isolation and characterization of naturally processed peptides bound by class II molecules and peptides presented by normal and mutant antigen-presenting cells. Chem Immunol (1993) 0.80
Generation and use of an antigen-specific hybrid to study B-cell function. J Mol Cell Immunol (1987) 0.79
Some biological properties of beta2-microglobulin and its antibody. Fed Proc (1976) 0.79
Class I MHC-peptide interactions: structural requirements and functional implications. Cancer Surv (1995) 0.79
Alpha 1-antitrypsin deficiency and common variable hypogammaglobulinemia in a patient with asthma. Chest (1982) 0.78
Design and testing of peptide-based cytotoxic T-cell-mediated immunotherapeutics to treat infectious diseases and cancer. Pharm Biotechnol (1995) 0.78
Human T-cell proliferation following PPD presentation by monocytes: inhibition by anti-beta 2-microglobulin. Clin Immunol Immunopathol (1980) 0.78
Unusual conditions for crystallization of the Fc fragment of chicken IgG. J Immunol (1969) 0.78
Involvement of the T cell antigen receptor and of Lyt-2 in the cytotoxic function of aged killer (AK) T cells. J Exp Med (1986) 0.77
Glycosylphosphatidyl inositol-linked membrane protein expression by intestinal intraepithelial lymphocytes. Int Immunol (1992) 0.76
Structure and function of beta2-microglobulin. Contemp Top Immunobiol (1976) 0.75
Serologic identification of the murine T3 homologue by cross-reactive xenogeneic anti-human T3 antisera. Mol Immunol (1987) 0.75
Antigen-specific and antibody-mediated growth inhibition of suppressor T cell hybridomas. Roles of H-2 and the CD3-T cell receptor-alpha/beta complex. J Immunol (1990) 0.75
Characterization of defective I-A surface expression in a mixed isotype expressing murine B cell lymphoma: continued expression of E alpha d A beta d despite competition from restored A alpha d A beta d pairs. Int Immunol (1992) 0.75
Class I MHC-peptide interaction: structural and functional aspects. Behring Inst Mitt (1994) 0.75
Inhibition by anti-beta2-microglobulin antisera of responder cells and not of stimulator cells in the mixed lymphocyte reaction. Scand J Immunol (1975) 0.75
Isolation and partial characterization of the major histocompatibility antigen in the chicken. Adv Exp Med Biol (1977) 0.75
[The T cell receptor for antigen--a review]. Tanpakushitsu Kakusan Koso (1986) 0.75
Analysis of MHC-specific peptide motifs. Applications in immunotherapy. Adv Exp Med Biol (1995) 0.75
Molecular weights of chicken, pheasant, and quail IgG immunoglobulins. Immunochemistry (1969) 0.75
Comparison of various avian and mammalian IgG immunoglobulins for salt-induced aggregation. J Immunol (1969) 0.75
Differential affinity of murine lymphocyte membrane IgM and IgD for the lentil lectin. Mol Immunol (1979) 0.75